November 14, 2006

FDC ENTERS INTO AN LICENSING AGREEMENT WITH GILEAD SCIENCES INC, FOR MANUFACTURING AND DISTRIBUTION OF GENERIC VERSIONS OF VIREAD IN THE DEVELOPING WORLD

FDC has entered into a non-exclusive license agreement with GILEAD Sciences Inc., for production and distribution of Tenofovir Disoproxil Fumarate (tenofovir DF) to 95 low-income countries around the world, including India. Tenofovir DF is sold by Gilead under the brand name Viread (R). In addition, this agreement also allows the manufacture of commercial quantities of both active pharmaceutical ingredient (API) and finished product.